Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.50 |
| ▸ | PARP1 | P09874 | 2/20 | 0.50 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.50 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.50 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terephthalamide SCHEMBL29109497 | 0.89 | PARP1 (0.62) | PARP10TSHRPARP4PARP1PARP15 | |
| SCHEMBL16171746 | 0.81 | PARP10 (0.48) | PARP10TSHRPARP4PARP1PARP15 | |
| Terephthalamide SCHEMBL23774 | 0.81 | PARP1 (0.71) | PARP10TSHRPARP4PARP1PARP15 | |
| SCHEMBL24689977 | 0.79 | TRPV1 (0.69) | CA2CA1 | |
| Hydrochlorthiazide SCHEMBL28867104 | 0.79 | CHEK2 (0.38) | PARP10TSHRPARP4PARP1PARP15 | |
| Terephthalamide SCHEMBL1906838 | 0.78 | PARP1 (0.67) | PARP10TSHRPARP4PARP1PARP15 | |
| Terephthalamide SCHEMBL15328883 | 0.78 | PARP1 (0.67) | PARP10TSHRPARP4PARP1PARP15 | |
| Terephthalamide SCHEMBL11512422 | 0.78 | PARP1 (0.67) | PARP10TSHRPARP4PARP1PARP15 | |
| Terephthalamide SCHEMBL7508927 | 0.78 | PARP1 (0.67) | PARP10TSHRPARP4PARP1PARP15 | |
| Terephthalamide SCHEMBL689841 | 0.78 | PARP1 (0.67) | PARP10TSHRPARP4PARP1PARP15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-119735600-A | 3-Ureido substituted thieno [2,3-b ] pyridine compound and preparation method and application thereof | 华东师范大学 | 2025-04-01 | — | — | CN | claimed |
| CN-119286228-A | High-resistant Wen Qianshui motor winding wire and preparation method thereof | 河北国潜线缆有限责任公司 | 2025-01-10 | — | — | CN | claimed |
| CN-115959993-B | Synthesis method of 2-aryl propionic acid compound | 山东中医药大学 | 2025-01-07 | — | — | CN | claimed |
| CN-119177083-A | Preparation and application of gamma-ray radiation resistant hetero element modified polyimide resin coating | 中国科学院兰州化学物理研究所 | 2024-12-24 | — | — | CN | claimed |
| US-12102715-B1 | ROS-responsive liposomes for specific targeting | VERILY LIFE SCIENCES LLC (US) | 2024-10-01 | — | — | US | claimed |
| WO-2024169524-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | 成都纽瑞特医疗科技股份有限公司 | 2024-08-22 | — | — | WO | claimed |
| WO-2024169525-A1 | BORON-CONTAINING DRUG AND PREPARATION METHOD THEREFOR | 成都纽瑞特医疗科技股份有限公司 | 2024-08-22 | — | — | WO | claimed |
| WO-2024016826-A1 | 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF | 杭州市第七人民医院 | 2024-01-25 | — | — | WO | claimed |
| EP-0927217-A4 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RES INST LTD (AU) | 2003-04-23 | — | — | EP | claimed |
| EP-0928306-A4 | ANTIVIRAL LINEAR POLYMERS | BIOMOLECULAR RES INST LTD (AU) | 2003-04-16 | — | — | EP | claimed |
| EP-1019414-A4 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMW SCIENT IND RES ORG (AU) | 2002-05-29 | — | — | EP | claimed |
| US-20020025919-A1 | Antiviral linear polymers | STARPHARMA PTY LIMITED (AU) | 2002-02-28 | — | — | US | claimed |
| EP-1019414-A1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-07-19 | — | — | EP | claimed |
| EP-0928306-A1 | ANTIVIRAL LINEAR POLYMERS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1999-07-14 | — | — | EP | claimed |
| EP-0927217-A1 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1999-07-07 | — | — | EP | claimed |
| WO-1999012940-A1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-03-18 | — | — | WO | claimed |
| WO-1998003572-A1 | ANTIVIRAL LINEAR POLYMERS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1998-01-29 | — | — | WO | claimed |
| WO-1998003573-A1 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1998-01-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020025919-A1 | Antiviral linear polymers | SARS1, MAVS, EIF2AK2 | PARP10 688/4885TSHR 4315/4885PARP4 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.